|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
US5916588A
(en)
|
1984-04-12 |
1999-06-29 |
The Liposome Company, Inc. |
Peptide-containing liposomes, immunogenic liposomes and methods of preparation and use
|
|
US6090406A
(en)
|
1984-04-12 |
2000-07-18 |
The Liposome Company, Inc. |
Potentiation of immune responses with liposomal adjuvants
|
|
US5057540A
(en)
|
1987-05-29 |
1991-10-15 |
Cambridge Biotech Corporation |
Saponin adjuvant
|
|
NZ230423A
(en)
|
1988-08-25 |
1993-08-26 |
Liposome Co Inc |
A dosage form comprising an antigen and a multilamellar liposome comprising dimyristolyphosphatidylcholine (dmpc) and cholesterol
|
|
DE3841091A1
(de)
|
1988-12-07 |
1990-06-13 |
Behringwerke Ag |
Synthetische antigene, verfahren zu ihrer herstellung und ihre verwendung
|
|
EP0378881B1
(en)
|
1989-01-17 |
1993-06-09 |
ENIRICERCHE S.p.A. |
Synthetic peptides and their use as universal carriers for the preparation of immunogenic conjugates suitable for the development of synthetic vaccines
|
|
JPH0832638B2
(ja)
|
1989-05-25 |
1996-03-29 |
カイロン コーポレイション |
サブミクロン油滴乳剤を含んで成るアジュバント製剤
|
|
FI920131A0
(fi)
|
1989-07-14 |
1992-01-13 |
Praxis Biolog Inc |
Cytokin- och hormonbaerare foer konjugatvaccin.
|
|
IT1237764B
(it)
|
1989-11-10 |
1993-06-17 |
Eniricerche Spa |
Peptidi sintetici utili come carriers universali per la preparazione di coniugati immunogenici e loro impiego per lo sviluppo di vaccini sintetici.
|
|
GB2276169A
(en)
|
1990-07-05 |
1994-09-21 |
Celltech Ltd |
Antibodies specific for carcinoembryonic antigen
|
|
DE69113564T2
(de)
|
1990-08-13 |
1996-05-30 |
American Cyanamid Co |
Faser-Hemagglutinin von Bordetella pertussis als Träger für konjugierten Impfstoff.
|
|
IT1262896B
(it)
|
1992-03-06 |
1996-07-22 |
|
Composti coniugati formati da proteine heat shock (hsp) e oligo-poli- saccaridi, loro uso per la produzione di vaccini.
|
|
NZ253137A
(en)
|
1992-06-25 |
1996-08-27 |
Smithkline Beecham Biolog |
Vaccine comprising antigen and/or antigenic composition, qs21 (quillaja saponaria molina extract) and 3 de-o-acylated monophosphoryl lipid a.
|
|
IL102687A
(en)
|
1992-07-30 |
1997-06-10 |
Yeda Res & Dev |
Conjugates of poorly immunogenic antigens and synthetic pepide carriers and vaccines comprising them
|
|
GB9326253D0
(en)
|
1993-12-23 |
1994-02-23 |
Smithkline Beecham Biolog |
Vaccines
|
|
US6429199B1
(en)
|
1994-07-15 |
2002-08-06 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules for activating dendritic cells
|
|
US6239116B1
(en)
|
1994-07-15 |
2001-05-29 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
|
US6207646B1
(en)
|
1994-07-15 |
2001-03-27 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
|
AU709586B2
(en)
|
1994-10-24 |
1999-09-02 |
Ophidian Pharmaceuticals, Inc. |
Vaccine and antitoxin for treatment and prevention of C. difficile disease
|
|
GB9513261D0
(en)
|
1995-06-29 |
1995-09-06 |
Smithkline Beecham Biolog |
Vaccines
|
|
NZ312502A
(en)
|
1995-07-07 |
1999-03-29 |
Oravax Inc |
Clostridium difficile toxins as mucosal adjuvants
|
|
US5707829A
(en)
|
1995-08-11 |
1998-01-13 |
Genetics Institute, Inc. |
DNA sequences and secreted proteins encoded thereby
|
|
CA2296765A1
(en)
|
1996-08-28 |
1998-03-05 |
Ophidian Pharmaceuticals, Inc. |
Soluble recombinant botulinum toxin proteins
|
|
AU753688B2
(en)
|
1997-03-10 |
2002-10-24 |
Ottawa Civic Loeb Research Institute |
Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant
|
|
GB9712347D0
(en)
|
1997-06-14 |
1997-08-13 |
Smithkline Beecham Biolog |
Vaccine
|
|
WO1998059053A1
(en)
|
1997-06-20 |
1998-12-30 |
Queen Mary & Westfield College |
Immonogenic fragments of toxin a of clostridium difficile
|
|
GB9713156D0
(en)
|
1997-06-20 |
1997-08-27 |
Microbiological Res Authority |
Vaccines
|
|
CA2302554C
(en)
|
1997-09-05 |
2007-04-10 |
Smithkline Beecham Biologicals S.A. |
Oil in water emulsions containing saponins
|
|
GB9725084D0
(en)
|
1997-11-28 |
1998-01-28 |
Medeva Europ Ltd |
Vaccine compositions
|
|
WO1999040936A2
(en)
|
1998-02-12 |
1999-08-19 |
American Cyanamid Company |
Pneumococcal and meningococcal vaccines formulated with interleukin-12
|
|
US6303114B1
(en)
|
1998-03-05 |
2001-10-16 |
The Medical College Of Ohio |
IL-12 enhancement of immune responses to T-independent antigens
|
|
HUP0101619A3
(en)
|
1998-04-09 |
2003-11-28 |
Smithkline Beecham Biolog |
Adjuvant compositions
|
|
US20020009429A1
(en)
*
|
1999-01-29 |
2002-01-24 |
Galagen, Inc. |
Pharmaceutical composition comprising a selected antigen and candida species antigen and methods
|
|
KR100642044B1
(ko)
|
1999-03-19 |
2006-11-10 |
글락소스미스클라인 바이오로지칼즈 에스.에이. |
백신
|
|
EP1165796A2
(en)
|
1999-04-09 |
2002-01-02 |
Techlab, Inc. |
Recombinant clostridium toxin a protein carrier for polysaccharide conjugate vaccines
|
|
JP2002542169A
(ja)
|
1999-04-09 |
2002-12-10 |
テクラブ， インコーポレイテッド |
Ｃｌｏｓｔｒｉｄｉｕｍｄｉｆｆｉｃｉｌｅに対する、組換え毒素Ａ／毒素Ｂワクチン
|
|
US6733760B1
(en)
*
|
1999-04-09 |
2004-05-11 |
Techlab, Inc. |
Recombinant toxin A/toxin B vaccine against Clostridium difficile
|
|
GB0007432D0
(en)
|
2000-03-27 |
2000-05-17 |
Microbiological Res Authority |
Proteins for use as carriers in conjugate vaccines
|
|
CA2409672A1
(en)
*
|
2000-05-10 |
2001-11-15 |
Glycodesign Inc. |
Designing modulators for glycosyltransferases
|
|
US7939087B2
(en)
|
2000-10-27 |
2011-05-10 |
Novartis Vaccines And Diagnostics, Inc. |
Nucleic acids and proteins from Streptococcus groups A & B
|
|
AU2002338233A1
(en)
*
|
2001-03-30 |
2002-10-15 |
Basf Plant Science Gmbh |
Glucan chain length domains
|
|
AU2002347404A1
(en)
|
2001-09-14 |
2003-04-01 |
Cytos Biotechnology Ag |
In vivo activation of antigen presenting cells for enhancement of immune responses induced by virus like particles
|
|
DE60234375D1
(de)
|
2001-09-14 |
2009-12-24 |
Cytos Biotechnology Ag |
VERPACKUNG VON IMMUNSTIMULIERENDEM CpG IN VIRUSÄHNLICHEN PARTIKELN: HERSTELLUNGSVERFAHREN UND VERWENDUNG
|
|
US7226597B2
(en)
|
2002-06-17 |
2007-06-05 |
The Board Of Regents Of The University Of Oklahoma |
Mutants of Clostridium difficile toxin B and methods of use
|
|
US20040235139A1
(en)
*
|
2002-12-23 |
2004-11-25 |
Demain Arnold L. |
Clostridium difficile culture and toxin production methods
|
|
NZ548821A
(en)
|
2004-02-06 |
2009-12-24 |
Univ Massachusetts |
Antibodies against clostridium difficile toxins and uses thereof
|
|
US20090087478A1
(en)
|
2004-12-27 |
2009-04-02 |
Progenics Pharmaceuticals (Nevada), Inc. |
Orally Deliverable and Anti-Toxin Antibodies and Methods for Making and Using Them
|
|
US20060228369A1
(en)
|
2005-04-11 |
2006-10-12 |
Program For Appropriate Technology In Health |
Stabilization and preservation of temperature-sensitive vaccines
|
|
WO2007146139A2
(en)
|
2006-06-08 |
2007-12-21 |
Cornell Research Foundation, Inc. |
Codon-optimized dna molecules encoding the receptor binding domains of clostridium difficile toxins a and b
|
|
ES2507553T3
(es)
|
2006-08-02 |
2014-10-15 |
Johannes Gutenberg-Universität Mainz |
Fármaco contra intoxicaciones por LCT
|
|
EP2167119B1
(en)
|
2007-06-14 |
2016-08-24 |
The Secretary of State for Health |
Chemically modified peptides with improved immunogenicity
|
|
WO2008156676A1
(en)
*
|
2007-06-15 |
2008-12-24 |
President And Fellows Of Harvard College |
Methods and compositions for detecting and modulating o-glycosylation
|
|
CA2733425A1
(en)
|
2008-08-06 |
2010-02-11 |
Emergent Product Development Uk Limited |
Vaccines against clostridium difficile and methods of use
|
|
US8709428B2
(en)
|
2009-02-20 |
2014-04-29 |
Health Protection Agency |
Antibodies to Clostridium difficile toxins
|
|
JP2013503198A
(ja)
*
|
2009-08-27 |
2013-01-31 |
シナプティック リサーチ，リミテッド ライアビリティ カンパニー |
人工多能性幹（ｉＰＳ）細胞または組織特異的細胞を誘導するための新規タンパク質送達系
|
|
US10046040B2
(en)
|
2009-11-16 |
2018-08-14 |
University Of Maryland, Baltimore |
Multivalent live vector vaccine against Clostridium difficile-associated disease
|
|
US20120282274A1
(en)
|
2009-11-20 |
2012-11-08 |
Northshore University Health System Research Institute |
Targeting of the c-terminal segment of c.difficile toxin b for improved clinical diagnosis, prevention, and treatment
|
|
JP2013512916A
(ja)
|
2009-12-02 |
2013-04-18 |
タフツ ユニバーシティー |
免疫原としてのＣｌｏｓｔｒｉｄｉｕｍｄｉｆｆｉｃｉｌｅの無毒の組換えホロトキシン
|
|
GB0921288D0
(en)
|
2009-12-04 |
2010-01-20 |
Health Prot Agency |
Therapies for preventing or suppressing clostridium difficile infection
|
|
CN102869778B
(zh)
|
2010-03-30 |
2015-05-20 |
菲尼克斯公司 |
重组毒素蛋白的高水平表达
|
|
MX339253B
(es)
*
|
2010-04-15 |
2016-05-18 |
Progenics Pharm Inc |
Anticuerpos para el tratamiento de infeccion y enfermedad asociadas con clostridium dificile.
|
|
CN103957931B
(zh)
|
2010-09-03 |
2017-10-24 |
瓦尔内瓦奥地利有限责任公司 |
艰难梭状芽胞杆菌毒素a和毒素b蛋白的分离多肽及其用途
|
|
US8431361B2
(en)
|
2010-09-17 |
2013-04-30 |
Board Of Regents Of The University Of Oklahoma |
Bacterial cells, optimized nucleotide sequences and methods for improved expression of recombinant Clostridium difficile toxin B
|
|
GB201016742D0
(en)
*
|
2010-10-05 |
2010-11-17 |
Health Prot Agency |
Clostridium difficile antigens
|
|
WO2012118693A1
(en)
|
2011-02-28 |
2012-09-07 |
Northshore University Healthsystem |
Methods of diagnosing clostridium difficile infection
|
|
CN103619871B
(zh)
*
|
2011-04-22 |
2016-12-14 |
惠氏有限责任公司 |
涉及突变体难辨梭菌毒素的组合物及其方法
|
|
CN107098977A
(zh)
|
2011-05-27 |
2017-08-29 |
葛兰素史密丝克莱恩生物有限公司 |
免疫原性组合物
|
|
AR087716A1
(es)
*
|
2011-08-31 |
2014-04-09 |
Valent Biosciences Corp |
Composiciones reguladoras del crecimiento de plantas, metodos de preparacion y usos de las mismas
|
|
AR089797A1
(es)
*
|
2012-01-27 |
2014-09-17 |
Merck Sharp & Dohme |
Vacunas contra clostridum difficile que comprenden toxinas recombinantes
|
|
GB201223342D0
(en)
*
|
2012-12-23 |
2013-02-06 |
Glaxosmithkline Biolog Sa |
Immunogenic composition
|